Related Experiment Videos
[Clinical trial with tibolone in postmenopausal replacement therapy]
A Zarate1, M Hernandez, R Ochoa
1Unidad de Investigación de Enfermedades Endocrinas, Hospital de Especialidades, Centro Médico Nacional, México.
Ginecologia Y Obstetricia De Mexico
|January 1, 1996
Summary
Tibolona effectively alleviates menopausal symptoms and improves sexual well-being in postmenopausal women. This hormone replacement therapy demonstrates safety and a low side effect profile.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Background:
- Estrogen deficiency is a primary change during the climacteric stage in women.
- Hormone replacement therapy (HRT) offers symptom relief and long-term benefits for cardiovascular disease and osteoporosis prevention.
- Individual experiences of estrogen deficiency vary in age of onset and symptom severity.
Purpose of the Study:
- To evaluate the effectiveness and safety of Tibolona as a novel pharmacological agent for hormone replacement therapy.
- To assess the impact of Tibolona on the psycho-emotional state and sexual function in postmenopausal women.
Main Methods:
- A study involving 36 postmenopausal women was conducted.
- The study assessed the efficacy and safety of Tibolona treatment.
- Data on side effects, psycho-emotional well-being, and sexual activity were collected.
Main Results:
- Tibolona was confirmed to be effective and safe for hormone replacement.
- A low occurrence of adverse side effects was observed.
- Significant improvements were noted in the psycho-emotional component and sexual satisfaction/activity.
Conclusions:
- Tibolona represents a safe and effective option for hormone replacement therapy in postmenopausal women.
- The therapy positively impacts psychological well-being and sexual function.
- Further research may explore long-term outcomes and broader applications.